Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in unlocking a …
Tag
Showing: 1 - 2 of 2 RESULTS
Novo
Novo Nordisk’s Wegovy Approved in China for Weight Loss
China has approved Novo Nordisk A/S’s blockbuster Wegovy for chronic weight management, opening up competition for next-generation obesity drugs in the world’s second-largest economy. China’s …